ausEE Inc. is Australia’s peak national support and patient advocacy organisation representing Australians living with an eosinophilic disease including eosinophilic gastrointestinal diseases (EGIDs) and eosinophilic oesophagitis (EoE).
We are a registered Australia wide charity whose mission is to improve the lives of those affected by eosinophilic diseases through providing support, evidence-based information, resources, advocacy and by campaigning to raise awareness and funds for research in Australia.
Donations to ausEE Inc. over $2 are tax deductible. All donations received will help us to achieve our mission. Please Donate here.
Eosinophils are a type of white blood cell that play a role in certain medical conditions and immune responses. If a person has too many eosinophils without another known cause, it may be because of an eosinophil-associated disease (EAD). The eosinophils build up and can cause inflammation and tissue damage. The diagnosis depends on where in the body the eosinophils are found. Eosinophilic gastrointestinal diseases (EGIDs) occur when eosinophils are in increased numbers in the gastrointestinal tract. Learn more...
We are a registered Australia wide charity whose mission is to improve the lives of those affected by eosinophilic diseases through providing support, evidence-based information, resources, advocacy and by campaigning to raise awareness and funds for research in Australia.
Donations to ausEE Inc. over $2 are tax deductible. All donations received will help us to achieve our mission. Please Donate here.
Eosinophils are a type of white blood cell that play a role in certain medical conditions and immune responses. If a person has too many eosinophils without another known cause, it may be because of an eosinophil-associated disease (EAD). The eosinophils build up and can cause inflammation and tissue damage. The diagnosis depends on where in the body the eosinophils are found. Eosinophilic gastrointestinal diseases (EGIDs) occur when eosinophils are in increased numbers in the gastrointestinal tract. Learn more...
Looking for Support?
Participate in Research
Featured Research
The CROSSING clinical research study is evaluating the safety and efficacy of tezepelumab for the treatment of Eosinophilic Esophagitis (EoE) in patients between 12 and 80 years of age.
To learn more about participating in the study you can visit the website https://eoetrialandyou.com/AusEE or call 1800948052 (Australia) / 0800441902 (New Zealand)
Read our latest Newsletter
Our Supporters:
Postal Address
ausEE Inc.PO Box 9923Frenchville Qld 4701